Literature DB >> 17984529

Forward-phase and reverse-phase protein microarray.

Yaping Zong1, Shanshan Zhang, Huang-Tsu Chen, Yunfei Zong, Yaxian Shi.   

Abstract

Protein microarray is a powerful tool for identifying disease biomarkers and therapeutical targets, and for systematically studying biological pathways with high efficiency. Although the protein microarray platform has been adopted by proteomic research and discovery, what remains problematic is how to maintain the activities and structures of printed proteins on slide surface. With the recent accomplishments in the R & D laboratory, now scientists around the world are able to preserve the biological functions of spotted proteins for high throughput analysis. Full Moon BioSystems (FMB) has developed general guidelines, which helps scientists efficiently prepare forward as well as reverse-phase protein microarray using FMB's proprietary polymer-coated slides, to obtain reliable and accurate array data with FMB's unique detection and analysis technology.

Mesh:

Substances:

Year:  2007        PMID: 17984529     DOI: 10.1007/978-1-59745-303-5_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate Cancer.

Authors:  Christelle P El-Haibi; Rajesh Singh; Pranav Gupta; Praveen K Sharma; Krysta N Greenleaf; Shailesh Singh; James W Lillard
Journal:  J Proteomics Bioinform       Date:  2012

Review 2.  Protein array diagnostics for guiding therapy in rheumatoid arthritis.

Authors:  Peter Szodoray; Philip Alex
Journal:  Mol Diagn Ther       Date:  2011-10-01       Impact factor: 4.074

3.  Receptor-binding domain-based immunoassays for serosurveillance differentiate efficiently between SARS-CoV2-exposed and non-exposed farmed mink.

Authors:  Jorge Pulido; Marga García-Durán; Ricardo Fernández-Antonio; Carmen Galán; Lissette López; Carmen Vela; Ángel Venteo; Paloma Rueda; Luis A Rivas
Journal:  J Vet Diagn Invest       Date:  2021-12-02       Impact factor: 1.279

4.  Proteomics and mass spectrometry: what have we learned about the heart?

Authors:  Shaan Chugh; Colin Suen; Anthony Gramolini
Journal:  Curr Cardiol Rev       Date:  2010-05

5.  Epidermal growth factor receptor cascade prioritizes the maximization of signal transduction.

Authors:  Kaori Kiso-Farnè; Tatsuaki Tsuruyama
Journal:  Sci Rep       Date:  2022-10-10       Impact factor: 4.996

6.  Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.

Authors:  Adriana Aguilar-Mahecha; Christiane Cantin; Maureen O'Connor-McCourt; Andre Nantel; Mark Basik
Journal:  Proteome Sci       Date:  2009-04-06       Impact factor: 2.480

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.